About Apium Pharmaceutical Private Limited
Data last updated:
Apium Pharmaceutical Private Limited is a private limited company based in Khalapur, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 April 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2009PTC192026. Its GSTIN is 27AAHCA7882Q1ZQ (Maharashtra).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Subhash Punjabrao Musale and Rekha Subhash Musale.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Khalapur, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹53.37 Lakh, a decline of 17% compared to the previous year. For the same year it recorded a net profit of ₹19,504 (net margin 0.4%) and EBITDA of ₹8.05 Lakh (EBITDA margin 15.1%). Revenue has declined at a compounded annual rate (CAGR) of 12% over three years and 5% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website apium.in.
Company details
Contact details
Apium Pharmaceutical Private Limited's registered office is in Khalapur, Maharashtra. Its website is apium.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressC/O Rekha S. Musale Fl – 104 Pl – 20 Sect – 5 Ulwe, Navi Mumbai, Khalapur, Maharashtra, India – 410206
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Apium Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Apium Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Apium Pharmaceutical Private Limited, buy the company report.
Financials of Apium Pharmaceutical Private Limited
FY 2025 filings availableApium Pharmaceutical Private Limited reported revenue of ₹53.37 Lakh (down 17% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 5% over five years, including a 17% fall in the latest year. EBITDA rose 45% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.05 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹19,504 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.1% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Apium Pharmaceutical Private Limited, buy the company report.
Board of directors of Apium Pharmaceutical Private Limited
Apium Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Subhash Punjabrao Musale | Director | 24 Apr 2009 | 17 Years 6 Months | Current |
| Rekha Subhash Musale | Director | 01 Dec 2012 | 13 Years 11 Months | Current |
Auditor
Apium Pharmaceutical Private Limited is audited by P G MANTRI & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P G MANTRI & ASSOCIATES | FY 2023 | 141124 |
Shareholding
The shareholding of Apium Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Apium Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Apium Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Apium Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Apium Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCA7882Q1ZQ | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Apium Pharmaceutical Private Limited, buy the company report.
Recent activity
Apium Pharmaceutical Private Limited has 3 board changes on record since 2009: 2 appointments and 1 cessation. The latest: Satish Keshavrao Munde ceased to be Director on 09 Dec 2012.
Frequently asked questions
Apium Pharmaceutical is an active private limited company based in Khalapur, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 April 2009 (17+ years old) and is registered under CIN U24239MH2009PTC192026.
Apium Pharmaceutical has 2 current directors:
- Subhash Punjabrao Musale - Director
- Rekha Subhash Musale - Director
The latest financial statements of Apium Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Apium Pharmaceutical is 27AAHCA7882Q1ZQ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Apium Pharmaceutical is U24239MH2009PTC192026. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apium Pharmaceutical was incorporated on 24 April 2009, making it 17+ years old. It is registered with the Registrar of Companies, Mumbai.
Satish Keshavrao Munde ceased to be Director on 09 Dec 2012. Rekha Subhash Musale was appointed as Director on 01 Dec 2012. Subhash Punjabrao Musale was appointed as Director on 24 Apr 2009.
Apium Pharmaceutical can be reached through the website apium.in. Its registered office is in Khalapur, Maharashtra, India.
The registered office of Apium Pharmaceutical is at CO Rekha S. Musale Fl – 104 Pl – 20 Sect – 5 Ulwe, Navi Mumbai, Khalapur, Maharashtra, India – 410206.
Apium Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
